Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$148.29 - $182.55 $252,093 - $310,335
-1,700 Reduced 38.64%
2,700 $400,000
Q2 2022

Aug 01, 2022

SELL
$155.97 - $200.09 $1.34 Million - $1.72 Million
-8,600 Reduced 66.15%
4,400 $756,000
Q1 2022

Apr 27, 2022

BUY
$181.39 - $234.03 $2.36 Million - $3.04 Million
13,000 New
13,000 $2.45 Million
Q4 2021

Jan 31, 2022

SELL
$193.69 - $247.03 $619,808 - $790,496
-3,200 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$189.29 - $209.69 $246,077 - $272,597
1,300 Added 68.42%
3,200 $621,000
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $140,310 - $169,191
900 Added 90.0%
1,900 $354,000
Q1 2021

May 03, 2021

BUY
$144.0 - $169.39 $144,000 - $169,390
1,000 New
1,000 $158,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Qvr LLC Portfolio

Follow Qvr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvr LLC with notifications on news.